CIPLA FDA Approval ANDA 210335

ANDA 210335

CIPLA

FDA Drug Application

Application #210335

Application Sponsors

ANDA 210335CIPLA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION150MG/ML0MEDROXYPROGESTERONE ACETATEMEDROXYPROGESTERONE ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2019-01-25STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210335
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEDROXYPROGESTERONE ACETATE","activeIngredients":"MEDROXYPROGESTERONE ACETATE","strength":"150MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/25\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-01-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.